Quick Takeaways
- Aberdeen Group plc filed SCHEDULE 13G/A for IMMUNIC, INC. Common Stock, par value $0.0001 per share (IMUX).
- Disclosed ownership: 6.8%.
- Date of event: 31 Dec 2025.
Aberdeen Group plc - 31 Dec 2025 SCHEDULE 13G/A Report for IMMUNIC, INC. Common Stock, par value $0.0001 per share (IMUX)
- Filing Manager
- Aberdeen Group plc
- Reporting Manager
- Aberdeen Group plc
- Symbol
- IMUX
- Shares outstanding
- 120,349,504 shares
- Disclosed Ownership
- 8,243,941 shares
- Ownership
- 6.8%
- Form type
- SCHEDULE 13G/A
- Filing time
- 02 Feb 2026, 10:31:36 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 31 Jul 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Aberdeen Group plc disclosed 6.8% ownership in IMMUNIC, INC. Common Stock, par value $0.0001 per share (IMUX) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 31 Jul 2025.
- Current filing was accepted on 02 Feb 2026, 10:31.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Aberdeen Group plc | 6.8% | 8,243,941 | 0 | 8,243,941 | F.Osei | Frederic Osei, Major Shareholding Reporting Analyst | |
| abrdn Inc. | 6.8% | 8,243,941 | 0 | 8,243,941 | F.Osei | Frederic Osei, Major Shareholding Reporting Analyst |